An award-winning biomedical researcher, entrepreneur and consultant, Gloria Izu, is set to create opportunities for researchers, entrepreneurs, and young professionals in the fields of biotech, ...

In the long run, onshoring of drug manufacturing in the US might limit WuXi's growth potential for the long run. Read why ...

PRGN-2012 has the potential to be the first- and best-in-class treatment for RRP Company's BLA for PRGN-2012 for the treatment of adults with RRP is under priority ...